Aspire Biopharma Holdings, Inc. (ASBP)
Nasdaq: ASBP · Pharmaceutical Preparations · Estero, FL · filing with the SEC since 2021
Who owns Aspire Biopharma Holdings, Inc.
As filed with the SECHolders of 5% or more
3
Lance Friedman holds 7.92% of Common Stock, as its SCHEDULE 13G/A filed Aug 6, 2026 says.
Directors and officers
0
report now, of 13 people on the record since 2022. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Lance Friedman
SCHEDULE 13G/A · filed Aug 6, 2026 · Common Stock · 4.52% in May 19, 2025
Gary Shirinyan
SCHEDULE 13G · filed Aug 10, 2026 · Common Stock, par value $0.0001 per share
Rubenbauer Alois Ryan III
SCHEDULE 13G · filed Jul 2, 2026 · Common Stock
Harraden Circle Investments, LLC
SCHEDULE 13G/A · filed May 15, 2025 · Class A Common Stock · reported falling below 5%
Highbridge Capital Management, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.2% in May 15, 2026
Ardsley Advisory Partners LP
SCHEDULE 13G/A · filed May 13, 2026 · Common Stock · reported falling below 5%, from 7.76% in Feb 12, 2026
What ASBP reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 11, 2024.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.